Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2017 | 3 |
2018 | 5 |
2024 | 0 |
Search Results
7 results
Results by year
Filters applied: . Clear all
Page 1
A comparative analysis of immune privilege in pregnancy and cancer in the context of checkpoint blockade immunotherapy.
Semin Oncol. 2018 Jun;45(3):170-175. doi: 10.1053/j.seminoncol.2018.03.005. Epub 2018 Mar 26.
Semin Oncol. 2018.
PMID: 30262396
Review.
Cancer: The Tumor-Driven Disease of the Host.
Janowitz T.
Janowitz T.
Cell Metab. 2018 Jul 3;28(1):5-6. doi: 10.1016/j.cmet.2018.06.016.
Cell Metab. 2018.
PMID: 29972797
Free article.
Item in Clipboard
A molecular and preclinical comparison of the PD-1-targeted T-cell checkpoint inhibitors nivolumab and pembrolizumab.
Fessas P, Lee H, Ikemizu S, Janowitz T.
Fessas P, et al.
Semin Oncol. 2017 Apr;44(2):136-140. doi: 10.1053/j.seminoncol.2017.06.002. Epub 2017 Jul 4.
Semin Oncol. 2017.
PMID: 28923212
Free PMC article.
Review.
Item in Clipboard
Cancer Immunotherapy Trials Underutilize Immune Response Monitoring.
Connell CM, Raby SEM, Beh I, Flint TR, Williams EH, Fearon DT, Jodrell DI, Janowitz T.
Connell CM, et al.
Oncologist. 2018 Jan;23(1):116-117. doi: 10.1634/theoncologist.2017-0226. Epub 2017 Oct 11.
Oncologist. 2018.
PMID: 29021379
Free PMC article.
Item in Clipboard
New Model for Estimating Glomerular Filtration Rate in Patients With Cancer.
Janowitz T, Williams EH, Marshall A, Ainsworth N, Thomas PB, Sammut SJ, Shepherd S, White J, Mark PB, Lynch AG, Jodrell DI, Tavaré S, Earl H.
Janowitz T, et al.
J Clin Oncol. 2017 Aug 20;35(24):2798-2805. doi: 10.1200/JCO.2017.72.7578. Epub 2017 Jul 7.
J Clin Oncol. 2017.
PMID: 28686534
Free PMC article.
Item in Clipboard
Rapid disease progression in a patient with mismatch repair-deficient and cortisol secreting adrenocortical carcinoma treated with pembrolizumab.
Casey RT, Giger O, Seetho I, Marker A, Pitfield D, Boyle LH, Gurnell M, Shaw A, Tischkowitz M, Maher ER, Chatterjee VK, Janowitz T, Mells G, Corrie P, Challis BG.
Casey RT, et al.
Semin Oncol. 2018 Jun;45(3):151-155. doi: 10.1053/j.seminoncol.2018.06.001. Epub 2018 Jun 21.
Semin Oncol. 2018.
PMID: 30262398
Free PMC article.
Item in Clipboard
A type III complement factor D deficiency: Structural insights for inhibition of the alternative pathway.
Sng CCT, O'Byrne S, Prigozhin DM, Bauer MR, Harvey JC, Ruhle M, Challis BG, Lear S, Roberts LD, Workman S, Janowitz T, Magiera L, Doffinger R, Buckland MS, Jodrell DJ, Semple RK, Wilson TJ, Modis Y, Thaventhiran JED.
Sng CCT, et al.
J Allergy Clin Immunol. 2018 Jul;142(1):311-314.e6. doi: 10.1016/j.jaci.2018.01.048. Epub 2018 Mar 6.
J Allergy Clin Immunol. 2018.
PMID: 29522842
Free PMC article.
No abstract available.
Item in Clipboard
Cite
Cite